Current State of Evidence for Medication Treatment of Preschool Internalizing Disorders
Psychotropic medications are being prescribed off-label by psychiatrists to treat preschool children diagnosed with internalizing disorders. In this review, the current state of evidence is presented for medications used to treat preschool children (ages 2–5 year olds) diagnosed with anxiety and/or...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | The Scientific World Journal |
| Online Access: | http://dx.doi.org/10.1155/2014/286085 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832549483975540736 |
|---|---|
| author | Justin A. Barterian Erin Rappuhn Erin L. Seif Gabriel Watson Hannah Ham John S. Carlson |
| author_facet | Justin A. Barterian Erin Rappuhn Erin L. Seif Gabriel Watson Hannah Ham John S. Carlson |
| author_sort | Justin A. Barterian |
| collection | DOAJ |
| description | Psychotropic medications are being prescribed off-label by psychiatrists to treat preschool children diagnosed with internalizing disorders. In this review, the current state of evidence is presented for medications used to treat preschool children (ages 2–5 year olds) diagnosed with anxiety and/or depressive disorders. Eleven studies were systematically identified for this review based on a priori criteria. Overall, the available literature revealed that studies addressing the medication treatment of internalizing disorders in preschoolers are extremely limited and represent relatively weak research methodologies. Given the increasing prevalence of the use of psychotropic medications to treat preschool children and the unique challenges associated with working with this population, it is imperative that mental health practitioners are aware of the current, albeit limited, research on this practice to help make informed treatment decisions. Suggestions about how to monitor potential costs and benefits in those unique cases in which psychopharmacological treatments might be considered for young children are given. Moreover, areas of additional research for this population are discussed. |
| format | Article |
| id | doaj-art-f4c6d7d8826e40218eb6525f573890b8 |
| institution | Kabale University |
| issn | 2356-6140 1537-744X |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | The Scientific World Journal |
| spelling | doaj-art-f4c6d7d8826e40218eb6525f573890b82025-02-03T06:11:20ZengWileyThe Scientific World Journal2356-61401537-744X2014-01-01201410.1155/2014/286085286085Current State of Evidence for Medication Treatment of Preschool Internalizing DisordersJustin A. Barterian0Erin Rappuhn1Erin L. Seif2Gabriel Watson3Hannah Ham4John S. Carlson5401c Erickson Hall, Michigan State University, East Lansing, MI 48824, USA401c Erickson Hall, Michigan State University, East Lansing, MI 48824, USA401c Erickson Hall, Michigan State University, East Lansing, MI 48824, USA401c Erickson Hall, Michigan State University, East Lansing, MI 48824, USA401c Erickson Hall, Michigan State University, East Lansing, MI 48824, USA401c Erickson Hall, Michigan State University, East Lansing, MI 48824, USAPsychotropic medications are being prescribed off-label by psychiatrists to treat preschool children diagnosed with internalizing disorders. In this review, the current state of evidence is presented for medications used to treat preschool children (ages 2–5 year olds) diagnosed with anxiety and/or depressive disorders. Eleven studies were systematically identified for this review based on a priori criteria. Overall, the available literature revealed that studies addressing the medication treatment of internalizing disorders in preschoolers are extremely limited and represent relatively weak research methodologies. Given the increasing prevalence of the use of psychotropic medications to treat preschool children and the unique challenges associated with working with this population, it is imperative that mental health practitioners are aware of the current, albeit limited, research on this practice to help make informed treatment decisions. Suggestions about how to monitor potential costs and benefits in those unique cases in which psychopharmacological treatments might be considered for young children are given. Moreover, areas of additional research for this population are discussed.http://dx.doi.org/10.1155/2014/286085 |
| spellingShingle | Justin A. Barterian Erin Rappuhn Erin L. Seif Gabriel Watson Hannah Ham John S. Carlson Current State of Evidence for Medication Treatment of Preschool Internalizing Disorders The Scientific World Journal |
| title | Current State of Evidence for Medication Treatment of Preschool Internalizing Disorders |
| title_full | Current State of Evidence for Medication Treatment of Preschool Internalizing Disorders |
| title_fullStr | Current State of Evidence for Medication Treatment of Preschool Internalizing Disorders |
| title_full_unstemmed | Current State of Evidence for Medication Treatment of Preschool Internalizing Disorders |
| title_short | Current State of Evidence for Medication Treatment of Preschool Internalizing Disorders |
| title_sort | current state of evidence for medication treatment of preschool internalizing disorders |
| url | http://dx.doi.org/10.1155/2014/286085 |
| work_keys_str_mv | AT justinabarterian currentstateofevidenceformedicationtreatmentofpreschoolinternalizingdisorders AT erinrappuhn currentstateofevidenceformedicationtreatmentofpreschoolinternalizingdisorders AT erinlseif currentstateofevidenceformedicationtreatmentofpreschoolinternalizingdisorders AT gabrielwatson currentstateofevidenceformedicationtreatmentofpreschoolinternalizingdisorders AT hannahham currentstateofevidenceformedicationtreatmentofpreschoolinternalizingdisorders AT johnscarlson currentstateofevidenceformedicationtreatmentofpreschoolinternalizingdisorders |